Fair opening price Current price
----------------------------------- -------------------
$1.38 $1.36 (Undervalued)
Is ADMA undervalued?
PB vs Industry: ADMA is overvalued based on its PB Ratio (2.6x) compared to the US Biotechs industry average (1.9x).
Is ADMA overvalued?
ADMA Biologics Inc - Hold Valuation metrics show that ADMA Biologics Inc may be overvalued. Its Value Score of F indicates it would be a bad pick for value investors. The financial health and growth prospects of ADMA, demonstrate its potential to underperform the market.
Is ADMA Biologics a good company?
ADMA Biologics Reviews FAQs 40% of ADMA Biologics employees would recommend working there to a friend based on Glassdoor reviews. Employees also rated ADMA Biologics 2.7 out of 5 for work life balance, 2.5 for culture and values and 2.7 for career opportunities.25 Nov 2021
Is ADMA a good stock buy?
Is ADMA Biologics a buy right now? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ADMA Biologics in the last twelve months. There are currently 4 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" ADMA Biologics stock.